Mes: febrero 2021

Women who were seen for treatment by Dr. James Heaps at UCLA medical facilities may be eligible to participate in a class action settlement

SEATTLE, Feb. 8, 2021 /PRNewswire-HISPANIC PR WIRE/ — A proposed class action Settlement may affect you if you were a woman seen for treatment by Dr. James Heaps («Dr. Heaps») at University of California Los Angeles («UCLA«) medical facilities during varying periods of time between January 1, 1983 and June 28, 2018.  The lawsuit pending in <span…

SEATTLE, Feb. 8, 2021 /PRNewswire-HISPANIC PR WIRE/ — A proposed class action Settlement may affect you if you were a woman seen for treatment by Dr. James Heaps («Dr. Heaps») at University of California Los Angeles («UCLA«) medical facilities during varying periods of time between January 1, 1983 and June 28, 2018.  The lawsuit pending in the United States District Court for the Central District of California is A.B. et al. v. Regents of the University of California et al., Case No. 2:20-cv-09555-RGK-E («lawsuit»).

What is the Lawsuit About?  The women who brought the lawsuit («Plaintiffs») allege that Dr. Heaps assaulted, abused, and engaged in harassing and offensive behavior towards female patients while he was an obstetrician and gynecologist at UCLA medical facilities and that Regents of the University of California («Regents») failed to respond appropriately.  Dr. Heaps and Regents («Defendants») deny Plaintiffs’ allegations.  The Court has not decided who is right.

Who Is Affected?  You are a «Class Member» if you are a woman who was seen for treatment by Dr. Heaps at (1) UCLA’s student health center (now Arthur Ashe Student Health and Wellness Center) from January 1, 1983 to June 30, 2010; (2) UCLA Medical Center (now Ronald Reagan UCLA Medical Center) from January 1, 1986 to June 28, 2018; or (3) Dr. Heaps’s medical offices at 100 UCLA Medical Plaza from February 1, 2014 to June 28, 2018.

What Can You Get from the Settlement?  The $73 million Settlement Fund will be used to pay Settlement Class Member claims and any Class Representative service awards approved by the Court.  In addition to monetary benefits, Regents will make institutional changes at UCLA.  The Settlement Fund will not be reduced to pay attorneys’ fees and costs or Administrative Expenses.

How Do You Get a Payment?  Settlement Class Members who are pre-identified and receive a Settlement Notice packet with a Claimant ID and women who submit a qualifying Statement of Class Membership will receive a Tier 1 Settlement payment of $2,500.  Settlement Class Members also have the option to submit a Tier 2 and Tier 3 Claim Form.  Depending on the information provided and whether claimants are willing to be interviewed, claimants could be awarded up to $250,000 (or more in exceptional circumstances).  The Statement of Class Membership and Tier 2 and Tier 3 Claim Form are available on the Settlement Website at www.UCLAHeapsSettlement.com or may be requested by phone toll-free at 1-888-921-0726.  All Claim Forms must be received online through the Settlement Website or postmarked by mail no later than June 7, 2021.

What Are Your Options?  Class Members who don’t want Settlement payment(s) and don’t want to be legally bound by the Settlement, must exclude themselves by May 6, 2021.  Class Members who do not request exclusion may object to the Settlement by May 6, 2021.  The detailed Settlement Notice provides detailed information regarding how to request exclusion or object.  The Court will hold a Fairness Hearing on July 12, 2021 at 9:00 a.m., Pacific, to consider whether the Settlement is fair, reasonable, and adequate.  Class Members may ask the Court to appear at the Fairness Hearing but don’t have to do so.

How Can You Get More Information?  This Notice is a summary.  Detailed Settlement information is available at www.UCLAHeapsSettlement.com.  You may also contact the Settlement Administrator by phone toll-free at 1-888-921-0726 or by mail at UCLA Heaps Settlement, c/o JND Legal Administration, P.O. Box 91386, Seattle, WA 98111.

 

SOURCE JND Legal Administration

Women who were seen for treatment by Dr. James Heaps at UCLA medical facilities may be eligible to participate in a class action settlement

SEATTLE, Feb. 8, 2021 /PRNewswire/ — A proposed class action Settlement may affect you if you were a woman seen for treatment by Dr. James Heaps («Dr. Heaps») at University of California Los Angeles («UCLA«) medical facilities during varying periods of time between January 1, 1983 and June 28, 2018.  The lawsuit pending in the…

SEATTLE, Feb. 8, 2021 /PRNewswire/ — A proposed class action Settlement may affect you if you were a woman seen for treatment by Dr. James Heaps («Dr. Heaps») at University of California Los Angeles («UCLA«) medical facilities during varying periods of time between January 1, 1983 and June 28, 2018.  The lawsuit pending in the United States District Court for the Central District of California is A.B. et al. v. Regents of the University of California et al., Case No. 2:20-cv-09555-RGK-E («lawsuit»).

What is the Lawsuit About?  The women who brought the lawsuit («Plaintiffs») allege that Dr. Heaps assaulted, abused, and engaged in harassing and offensive behavior towards female patients while he was an obstetrician and gynecologist at UCLA medical facilities and that Regents of the University of California («Regents») failed to respond appropriately.  Dr. Heaps and Regents («Defendants») deny Plaintiffs’ allegations.  The Court has not decided who is right.

Who Is Affected?  You are a «Class Member» if you are a woman who was seen for treatment by Dr. Heaps at (1) UCLA’s student health center (now Arthur Ashe Student Health and Wellness Center) from January 1, 1983 to June 30, 2010; (2) UCLA Medical Center (now Ronald Reagan UCLA Medical Center) from January 1, 1986 to June 28, 2018; or (3) Dr. Heaps’s medical offices at 100 UCLA Medical Plaza from February 1, 2014 to June 28, 2018.

What Can You Get from the Settlement?  The $73 million Settlement Fund will be used to pay Settlement Class Member claims and any Class Representative service awards approved by the Court.  In addition to monetary benefits, Regents will make institutional changes at UCLA.  The Settlement Fund will not be reduced to pay attorneys’ fees and costs or Administrative Expenses.

How Do You Get a Payment?  Settlement Class Members who are pre-identified and receive a Settlement Notice packet with a Claimant ID and women who submit a qualifying Statement of Class Membership will receive a Tier 1 Settlement payment of $2,500.  Settlement Class Members also have the option to submit a Tier 2 and Tier 3 Claim Form.  Depending on the information provided and whether claimants are willing to be interviewed, claimants could be awarded up to $250,000 (or more in exceptional circumstances).  The Statement of Class Membership and Tier 2 and Tier 3 Claim Form are available on the Settlement Website at www.UCLAHeapsSettlement.com or may be requested by phone toll-free at 1-888-921-0726.  All Claim Forms must be received online through the Settlement Website or postmarked by mail no later than June 7, 2021.

What Are Your Options?  Class Members who don’t want Settlement payment(s) and don’t want to be legally bound by the Settlement, must exclude themselves by May 6, 2021.  Class Members who do not request exclusion may object to the Settlement by May 6, 2021.  The detailed Settlement Notice provides detailed information regarding how to request exclusion or object.  The Court will hold a Fairness Hearing on July 12, 2021 at 9:00 a.m., Pacific, to consider whether the Settlement is fair, reasonable, and adequate.  Class Members may ask the Court to appear at the Fairness Hearing but don’t have to do so.

How Can You Get More Information?  This Notice is a summary.  Detailed Settlement information is available at www.UCLAHeapsSettlement.com.  You may also contact the Settlement Administrator by phone toll-free at 1-888-921-0726 or by mail at UCLA Heaps Settlement, c/o JND Legal Administration, P.O. Box 91386, Seattle, WA 98111.

 

Cision View original content:http://www.prnewswire.com/news-releases/women-who-were-seen-for-treatment-by-dr-james-heaps-at-ucla-medical-facilities-may-be-eligible-to-participate-in-a-class-action-settlement-301213301.html

SOURCE JND Legal Administration

Las mujeres que fueron atendidas por el Dr. James Heaps en las instalaciones médicas de UCLA pueden tener derecho a participar en un acuerdo de demanda colectiva

SEATTLE, 8 de febrero de 2021 /PRNewswire-HISPANIC PR WIRE/ — Un Acuerdo de demanda colectiva propuesto puede afectarla si usted fue una mujer atendida por el Dr. James Heaps («Dr. Heaps») en las instalaciones médicas de la Universidad de California en Los Ángeles («UCLA«) durante diferentes períodos de tiempo entre el 1 de enero de 1983 y el 28 de junio de 2018.  La demanda pendiente en el Tribunal de Distrito de los Estados Unidos…

SEATTLE, 8 de febrero de 2021 /PRNewswire-HISPANIC PR WIRE/ — Un Acuerdo de demanda colectiva propuesto puede afectarla si usted fue una mujer atendida por el Dr. James Heaps («Dr. Heaps») en las instalaciones médicas de la Universidad de California en Los Ángeles («UCLA«) durante diferentes períodos de tiempo entre el 1 de enero de 1983 y el 28 de junio de 2018.  La demanda pendiente en el Tribunal de Distrito de los Estados Unidos para el Distrito Central de California es A.B. et al. v. Regents of the University of California et al., Caso No. 2:20-cv-09555-RGK-E («demanda»).

¿De qué se trata la demanda?  Las mujeres que entablaron la demanda («Demandantes») alegan que el Dr. Heaps agredió, abusó y se involucró en un comportamiento hostigador y ofensivo hacia pacientes femeninas mientras era obstetra y ginecólogo en las instalaciones médicas de UCLA y que los Regentes de la Universidad de California («Regentes») no respondieron adecuadamente.  El Dr. Heaps y los Regentes («Demandados») niegan las acusaciones de las Demandantes.  El Tribunal no ha decidido quién tiene razón.

¿Quiénes se ven afectados ?  Usted es un «Miembro de la clase» si es una mujer que fue atendida por el Dr. Heaps en (1) el centro de salud para estudiantes de UCLA (ahora Centro de Bienestar y Salud para Estudiantes Arthur Ashe) del 1 de enero de 1983 al 30 de junio de 2010; (2) UCLA Medical Center (ahora Centro Médico Ronald Reagan de UCLA) del 1 de enero de 1986 al 28 de junio de 2018; o (3) el consultorio médico del Dr. Heaps ubicado en 100 UCLA Medical Plaza desde el 1 de febrero de 2014 hasta el 28 de junio de 2018.

¿Qué puede obtener del Acuerdo?  El Fondo del acuerdo de $73 millones se utilizará para pagar las reclamaciones de los Miembros del grupo del acuerdo y cualquier adjudicación de servicio del Representante del grupo aprobado por el Tribunal.  Además de los beneficios monetarios, los Regentes harán cambios institucionales en UCLA.  El Fondo del acuerdo no se reducirá para pagar los honorarios y costos de los abogados o los Gastos administrativos.

¿Cómo se obtiene un pago ?  Los Miembros del grupo del acuerdo que estén identificados previamente y reciban un paquete de Aviso del acuerdo con una Identificación de reclamante y las mujeres que presenten una Declaración de membresía del grupo que cumplan con los requisitos recibirán un pago del Acuerdo de Nivel 1 de $2,500.  Los Miembros del grupo del acuerdo también tienen la opción de enviar un formulario de reclamación de Nivel 2 y Nivel 3.  Dependiendo de la información proporcionada y de si los reclamantes están dispuestos a ser entrevistados, los reclamantes podrían recibir hasta $250,000 (o más en circunstancias excepcionales).  La Declaración de Membresía de clase y el Formulario de reclamación de Nivel 2 y Nivel 3 están disponibles en el sitio web del Acuerdo en www.UCLAHeapsSettlement.com o pueden solicitarse por teléfono sin cargo al 1-888-921-0726.  Todos los Formularios de reclamación deben recibirse en línea a través del sitio web del Acuerdo o deben enviarse por correo postal a más tardar el 7 de junio de 2021.

¿Cuáles son sus opciones ?  Los Miembros de la clase que no desean pagos del Acuerdo y no quieren estar legalmente vinculados por el Acuerdo, deben excluirse antes del 6 de mayo de 2021.  Los Miembros de la clase que no soliciten la exclusión pueden objetar el Acuerdo antes del 6 de mayo de 2021.  El Aviso detallado del acuerdo proporciona información detallada sobre cómo solicitar la exclusión u objetar.  El Tribunal celebrará una Audiencia de imparcialidad el 12 de julio de 2021 a las 9:00 a.m., hora del Pacífico, para considerar si el Acuerdo es justo, razonable y adecuado.  Los Miembros de la clase pueden pedirle al Tribunal que comparezca en la Audiencia de imparcialidad, pero no es necesario que lo haga.

¿Cómo puede obtener más información ?  Este Aviso es un resumen.  La información detallada del Acuerdo está disponible en www.UCLAHeapsSettlement.com.  También puede comunicarse con el Administrador del acuerdo por teléfono sin cargo al 1-888-921-0726 o por correo postal a UCLA Heaps Settlement, c/o JND Legal Administration, PO Box 91386, Seattle, WA 98111.

 

 

FUENTE JND Legal Administration

Women who were seen for treatment by Dr. James Heaps at UCLA medical facilities may be eligible to participate in a class action settlement

SEATTLE, Feb. 8, 2021 /PRNewswire-HISPANIC PR WIRE/ — A proposed class action Settlement may affect you if you were a woman seen for treatment by Dr. James Heaps («Dr. Heaps») at University of California Los Angeles («UCLA«) medical facilities during varying periods of time between January 1, 1983 and June 28, 2018.  The lawsuit pending in <span…

SEATTLE, Feb. 8, 2021 /PRNewswire-HISPANIC PR WIRE/ — A proposed class action Settlement may affect you if you were a woman seen for treatment by Dr. James Heaps («Dr. Heaps») at University of California Los Angeles («UCLA«) medical facilities during varying periods of time between January 1, 1983 and June 28, 2018.  The lawsuit pending in the United States District Court for the Central District of California is A.B. et al. v. Regents of the University of California et al., Case No. 2:20-cv-09555-RGK-E («lawsuit»).

What is the Lawsuit About?  The women who brought the lawsuit («Plaintiffs») allege that Dr. Heaps assaulted, abused, and engaged in harassing and offensive behavior towards female patients while he was an obstetrician and gynecologist at UCLA medical facilities and that Regents of the University of California («Regents») failed to respond appropriately.  Dr. Heaps and Regents («Defendants») deny Plaintiffs’ allegations.  The Court has not decided who is right.

Who Is Affected?  You are a «Class Member» if you are a woman who was seen for treatment by Dr. Heaps at (1) UCLA’s student health center (now Arthur Ashe Student Health and Wellness Center) from January 1, 1983 to June 30, 2010; (2) UCLA Medical Center (now Ronald Reagan UCLA Medical Center) from January 1, 1986 to June 28, 2018; or (3) Dr. Heaps’s medical offices at 100 UCLA Medical Plaza from February 1, 2014 to June 28, 2018.

What Can You Get from the Settlement?  The $73 million Settlement Fund will be used to pay Settlement Class Member claims and any Class Representative service awards approved by the Court.  In addition to monetary benefits, Regents will make institutional changes at UCLA.  The Settlement Fund will not be reduced to pay attorneys’ fees and costs or Administrative Expenses.

How Do You Get a Payment?  Settlement Class Members who are pre-identified and receive a Settlement Notice packet with a Claimant ID and women who submit a qualifying Statement of Class Membership will receive a Tier 1 Settlement payment of $2,500.  Settlement Class Members also have the option to submit a Tier 2 and Tier 3 Claim Form.  Depending on the information provided and whether claimants are willing to be interviewed, claimants could be awarded up to $250,000 (or more in exceptional circumstances).  The Statement of Class Membership and Tier 2 and Tier 3 Claim Form are available on the Settlement Website at www.UCLAHeapsSettlement.com or may be requested by phone toll-free at 1-888-921-0726.  All Claim Forms must be received online through the Settlement Website or postmarked by mail no later than June 7, 2021.

What Are Your Options?  Class Members who don’t want Settlement payment(s) and don’t want to be legally bound by the Settlement, must exclude themselves by May 6, 2021.  Class Members who do not request exclusion may object to the Settlement by May 6, 2021.  The detailed Settlement Notice provides detailed information regarding how to request exclusion or object.  The Court will hold a Fairness Hearing on July 12, 2021 at 9:00 a.m., Pacific, to consider whether the Settlement is fair, reasonable, and adequate.  Class Members may ask the Court to appear at the Fairness Hearing but don’t have to do so.

How Can You Get More Information?  This Notice is a summary.  Detailed Settlement information is available at www.UCLAHeapsSettlement.com.  You may also contact the Settlement Administrator by phone toll-free at 1-888-921-0726 or by mail at UCLA Heaps Settlement, c/o JND Legal Administration, P.O. Box 91386, Seattle, WA 98111.

 

SOURCE JND Legal Administration

Delivery of zero-emission refridgerated trailers for leasing by PLM Fleet, LLC

NEWARK, N.J., Feb. 8, 2021 /PRNewswire/ — Marubeni Corporation (hereinafter «Marubeni») and Mizuho Leasing Company, Limited (hereinafter «Mizuho Leasing») have begun delivery of zero-emission (*) refrigerated trailers designed and manufactured by Advanced Energy Machines (hereinafter referred to as «AEM») in the United States to customers in December last year through PLM Fleet, LLC (hereinafter «PLM»), a U.S.-based refrigerated trailer leasing and rental…

NEWARK, N.J., Feb. 8, 2021 /PRNewswire/ — Marubeni Corporation (hereinafter «Marubeni») and Mizuho Leasing Company, Limited (hereinafter «Mizuho Leasing») have begun delivery of zero-emission (*) refrigerated trailers designed and manufactured by Advanced Energy Machines (hereinafter referred to as «AEM») in the United States to customers in December last year through PLM Fleet, LLC (hereinafter «PLM»), a U.S.-based refrigerated trailer leasing and rental business.

As a leader in the U.S. cold chain supply industry, PLM has been educating refrigerated fleet operators on the viability of zero-emission refrigerated trailers, holding joint exhibitions and lectures with AEM, since 2019. In May 2020, PLM signed an agreement with AEM and started sales activities in the U.S. market. PLM has since signed agreements with major customers and began delivery of zero-emission refrigerated trailers in 2020. Interest and demand for the zero-emission technology is steadily increasing as the technology continues to prove itself as a viable alternative to diesel.

In the United States, hybridization and electrification are accelerating in not only passenger cars and trucks, but also refrigerated trailers equipped with transport refrigeration units traditionally powered by diesel engines. Companies have begun to transition fleet equipment to green alternatives leveraging lease flexibility as an important tool in the change. The state of California is leading the way with guidance aimed at accelerating the reduction of harmful pollutants by providing support for zero-emission vehicles and equipment as well as infrastructure and distributed energy solutions.

Compared to diesel powered transport refrigeration units (hereinafter «TRUs»), AEM zero-emission technology eliminates many tons of carbon dioxide annually while also eliminating harmful nitrogen oxides. In addition to helping the environment, the AEM TRUs use low-voltage, safe charging to greatly reduce the risk of electric shock to equipment users. Available across all trailer sizes and configurations, including multiple temperature applications, the AEM TRUs use battery technology along with solar and momentum generation to extend useful routes before recharging.

Through PLM, Marubeni and Mizuho Leasing will contribute to deliver low-carbon and sustainable solutions by expanding environmentally focused products with advanced technology in the cold chain market, which will continue to grow and evolve in the years to come.

(*) Zero emission: No exhaust gas such as carbon dioxide and nitrogen oxides discharged while driving.

Contact: Nicole Greco 862-229-6480 ngreco@plmfleet.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/delivery-of-zero-emission-refridgerated-trailers-for-leasing-by-plm-fleet-llc-301223532.html

SOURCE PLM Fleet, LLC

CBAK Energy Announces $70 Million Registered Direct Offering Priced At the Market Under Nasdaq Rules

DALIAN, China, Feb. 8, 2021 /PRNewswire/ — CBAK Energy Technology, Inc.  («CBAK Energy», or the «Company,» NASDAQ: CBAT), a leading lithium-ion battery manufacturer and electric energy solution provider, today announced that it has entered into a securities purchase agreement (the «Agreement») with certain institutional investors for a registered direct placement of approximately $70 million of its common stock, priced at the market under applicable Nasdaq rules with …

DALIAN, China, Feb. 8, 2021 /PRNewswire/ — CBAK Energy Technology, Inc.  («CBAK Energy», or the «Company,» NASDAQ: CBAT), a leading lithium-ion battery manufacturer and electric energy solution provider, today announced that it has entered into a securities purchase agreement (the «Agreement») with certain institutional investors for a registered direct placement of approximately $70 million of its common stock, priced at the market under applicable Nasdaq rules with  a price of $7.83 per share. As part of the Agreement, the Company will issue certain Series A-1 Warrants to the investors to purchase a total of 4,469,988 shares of common stock and certain Series A-2 Warrants to purchase up to 2,234,992 shares of common stock, both of which are at a purchase price of $7.67 per share.   Series A-1 Warrants and Series A-2 Warrants are exercisable for 42 months and 45 months, respectively, from the issue date. The Company will also issue certain Series B Warrants to the investors to purchase a total of 4,469,988 shares of common stock at a purchase price of $7.83 per share, which are exercisable for 90 days from the issue date.

The Company intends to use the net proceeds from the offering to further accelerate the Company’s business plan, repay some of its outstanding debts, and fund any additional working capital needs.

The offering is expected to close on or about February 10, 2021, subject to the satisfaction of customary closing conditions.

FT Global Capital, Inc. acted as the exclusive placement agent for the offering.

The common stock, Series B Warrants, Series A-2 Warrants and the common stock issuable upon the exercise of Series B Warrants and Series A-2 Warrants being offered pursuant to the registered direct offering are being sold pursuant to a shelf registration statement on Form S-3 (File No. 333-250893), previously filed with the Securities and Exchange Commission (the «SEC») and declared effective on December 3, 2020. Such securities are being offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A prospectus supplement and the accompanying prospectus relating to and describing the terms of the registered direct offering will be filed with the SEC. The Series A-1 Warrants being offered in the concurrent private placement, along with the underlying common stock, have not been registered under the Securities Act of 1933, as amended (the «Securities Act») and are sold pursuant to an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D promulgated thereunder.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

For further details of this transaction, please see the Form 8-K to be filed with the SEC. 

About CBAK Energy Technology, Inc.

CBAK Energy Technology, Inc. (NASDAQ: CBAT) is a leading high-tech enterprise engaged in the R&D, manufacture, and sales of high power lithium batteries. The application of its products and solutions covers such areas as electric vehicles, light electric vehicles, electric tools, transportation and energy storage. As the first lithium battery company in China listed in NASDAQ in 2006, CBAK Energy possesses China’s first production base specially engaged in power battery, and has multiple operating subsidiaries in both Dalian and Nanjing and a large-scale R&D and production base in Dalian.

For more information, please visit www.cbak.com.cn

Safe Harbor Statement 

This press release contains certain statements that may include «forward-looking statements.» All statements other than statements of historical fact included herein are «forward-looking statements.» These forward-looking statements are often identified by the use of forward-looking terminology such as «believes,» «expects» or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on the SEC’s website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the applicable securities laws, the Company does not assume a duty to update these forward-looking statements.

For More Information: 

CBAK Energy Technology, Inc.
Ms. Yuna Pei 
Phone: +86-0411-39185900 
Email: IR@cbak.com.cn

Cision View original content:http://www.prnewswire.com/news-releases/cbak-energy-announces-70-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-301223943.html

SOURCE CBAK Energy Technology, Inc.

Global NDT Inspection Services Markets, 2020-2025 – Growth Opportunitities in IoT Connectivity and Digitalization Across Vertical Markets FOR Visibility and Profitability

DUBLIN, Feb. 8, 2021 /PRNewswire/ — The «Third-party NDT Technologies to Drive…

DUBLIN, Feb. 8, 2021 /PRNewswire/ — The «Third-party NDT Technologies to Drive the Global NDT Inspection Services Market Growth, 2020» report has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo

The global non-destructive testing (NDT) services market revenue in 2020 is $8,865.9 million and is expected to grow at a compound annual growth rate (CAGR) of 3.2% between 2020 and 2025.

North America (NA) is the biggest market for NDT services, holding 32.4% of the global revenue. The Asia-Pacific (APAC) region is expected to witness the highest CAGR of 3.6% between 2020 and 2025. NA, however, is likely to continue being the biggest revenue contributor by 2025, with 32.2% of the global revenue share.

The ultrasonic testing technology is the most in use, with revenue of $3,874.4 million in 2020, and is expected to continue holding the majority revenue share during the forecast period. Radiography is the other more popular technique, comprising 25.8% of the market share in 2020, and is set to record a 3.1% CAGR between 2020 and 2025.

The oil and gas vertical market is the biggest revenue contributor, with a 47.6% revenue share. Within oil and gas, the midstream business is the biggest revenue contributor, followed by upstream. The oil and gas downstream vertical market is the smallest segment within the oil and gas industry.

Power is the second-biggest vertical, holding 17.4% of the total global revenue in 2020. The automotive vertical is witnessing a sharp decline in 2020 but is expected to grow at a CAGR of 6.3% between 2020 and 2025. The railways vertical market is likely to attain a CAGR of 4.3% between 2020 and 2025.

The NDT services market is highly competitive, with about 900 participants and the top 7 participants holding 44.1% of the market share globally. Services providers are consistently coming up with technologies and accurate and high-quality solutions. Most market participants offer ultrasonic and radiography testing technologies. Because of the increase in equipment cost and the requirement for highly skilled workforces, companies have begun outsourcing their NDT needs, resulting in NDT services market growth.

Additionally, governments and industry regulatory bodies have strict mandates on industry safety norms that companies have to adhere to. This is also pushing companies to adopt NDT services. As the market is highly competitive, leading participants, Tier-II companies, and start-ups compete on similar solutions offerings.

Companies demonstrating product innovation time and again have been able to stay ahead of their peers in the competitive environment. Market leaders also focus on inorganic growth to expand their product portfolio and customer base.

Key Issues Addressed

  • Is the market growing? How long will it continue to grow and at what rate?
  • What are the fast-growing key geographies and segments?
  • What are the vertical markets with high demand and high growth opportunities?
  • What are the emerging market trends?
  • Which are the leading vendors and what is the competitive landscape like?

Key Topics Covered:

1. Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative
  • The Impact of Strategic Imperative on the NDT Services Market
  • Growth Opportunities Fuel the Growth Pipeline Engine

2. Growth Opportunity Analysis – NDT Services Market

  • NDT Services Market Scope of Analysis
  • NDT Services Market Segmentation
  • Key Competitors for NDT Services Market
  • Key Growth Metrics for NDT Services Market
  • Growth Drivers for NDT Services Market
  • Growth Driver Analysis for NDT Services Market
  • Growth Restraints for NDT Services Market
  • Growth Restraint Analysis for NDT Services Market
  • Forecast Assumptions – NDT Services Market
  • Revenue Forecast – NDT Services Market
  • Revenue Forecast by Technology – NDT Services Market
  • Revenue Forecast by Vertical Market – NDT Services Market
  • Revenue Forecast by Region – NDT Services Market
  • Revenue Forecast Analysis – NDT Services Market
  • Revenue Forecast Analysis by Technology – NDT Services Market
  • Revenue Forecast Analysis by Region – NDT Services Market
  • Revenue Forecast Analysis by Vertical Market – NDT Services Market
  • Competitive Environment – NDT Services Market
  • Market Share Analysis – NDT Services Market

3. Growth Opportunity Analysis – NDT Services Market: North America

  • Key Growth Metrics – NDT Services Market: North America
  • Key Findings – NDT Services Market: North America
  • Revenue Forecast – NDT Services Market: North America
  • Revenue Forecast by Technology for NDT Services Market – North America
  • Revenue Forecast by Vertical Market for NDT Services Market – North America
  • Revenue Forecast Analysis – NDT Services Market: North America

4. Growth Opportunity Analysis – NDT Services Market: Europe

5. Growth Opportunity Analysis – NDT Services Market: APAC

6. Growth Opportunity Analysis – NDT Services Market: Rest of the World

7. Growth Opportunities – NDT Services Market

  • Growth Opportunity 1: IoT Connectivity and Digitalization Across Vertical Markets FOR Visibility and Profitability
  • Growth Opportunity 2: AI and Big Data Analytics for Predicting the Life Cycle

8. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/arlb54

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-ndt-inspection-services-markets-2020-2025—growth-opportunitities-in-iot-connectivity-and-digitalization-across-vertical-markets-for-visibility-and-profitability-301223808.html

SOURCE Research and Markets

Quick Hit Slots™ Players Donate Thousands of Toys to Toys for Tots

AUSTIN, Texas, Feb. 8, 2021 /PRNewswire/ — SciPlay (NASDAQ: SCPL) («SciPlay» or the «Company»), an industry-leading social gaming Company, donated more than $18,700 to Toys for Tots through the generosity of its players on <a target="_blank"…

AUSTIN, Texas, Feb. 8, 2021 /PRNewswire/ — SciPlay (NASDAQ: SCPL) («SciPlay» or the «Company»), an industry-leading social gaming Company, donated more than $18,700 to Toys for Tots through the generosity of its players on Quick Hit Slots. The Toys for Tots program collects new toys to give to less fortunate children so they can experience the joy of opening gifts on Christmas morning. Thanks to SciPlay’s fundraising, Toys for Tots donated more than 3,700 toys to children during the holiday season.

Quick Hit Slots features some of the biggest casino names and brands, including Dancing Drums™, Cash Spin™, Mayan Treasures™, Lock It Links™ and Havana Cubana™. Through an interactive, in-game experience, more than one million Quick Hit Slots’ monthly active users accrued «magic points» to contribute to SciPlay’s toy donations between December 10 and 26. For every 50,000 points earned, SciPlay donated one toy to Toys for Tots.

«There is nothing more heartwarming than engaging our wonderful user base to help those in need,» said Diego Alaluf, Director of Marketing for Quick Hit Slots at SciPlay. «We wanted to give back to the community this holiday season and are proud to have partnered with Toys for Tots again to deliver toys to children in need. Everyone has the right to play, and we are very appreciative of our gracious users and are overjoyed to have helped Santa deliver thousands of toys to children throughout the world!»

Quick Hit Slots users celebrated the donation opportunity through the app’s community page.

«Thank you for your great gift…that is an amazing gesture,» one user commented.

Another user added, «It’s a good feeling knowing you gave a helping hand…keep doing good, Quick Hit community.»

To learn more about SciPlay, Quick Hit Slots and the Company’s dozens of social casino games, visit sciplay.com.

© 2021 SciPlay. All Rights Reserved.

About SciPlay
SciPlay Corporation (NASDAQ: SCPL) is a leading developer and publisher of digital games on mobile and web platforms. SciPlay currently offers seven core games, including social casino games Jackpot Party Casino, Gold Fish Casino, Hot Shot Casino and Quick Hit Slots, and casual games MONOPOLY Slots, Bingo Showdown and 88 Fortunes Slots. SciPlay’s social casino games feature slots-style game play and occasionally table games-style game play, while its casual games blend slots-style or bingo game play with adventure game features. All of SciPlay’s games are offered and played on multiple platforms, including Apple, Google, Facebook and Amazon. In addition to developing original games, SciPlay has access to a library of more than 1,500 real-world slot and table games provided by Scientific Games Corporation and its Subsidiaries. For more information, please visit sciplay.com.

Forward-Looking Statements
In this press release, SciPlay makes «forward-looking statements» within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as «will,» «may,» and «should.» These statements are based upon management’s current expectations, assumptions and estimates and are not guarantees of timing, future results or performance. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. Actual results may differ materially from those contemplated in these statements due to a variety of risks, uncertainties and other factors, including those factors described in our filings with the Securities and Exchange Commission (the «SEC»), including SciPlay’s current reports on Form 8-K, quarterly reports on Form 10-Q and its latest annual report on Form 10-K filed with the SEC on February 18, 2020 (including under the headings «Forward-Looking Statements» and «Risk Factors»). Forward-looking statements speak only as of the date they are made and, except for SciPlay’s ongoing obligations under the U.S. federal securities laws, SciPlay undertakes no obligation to publicly update any forward-looking statements whether as a result of new information, future events or otherwise.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/quick-hit-slots-players-donate-thousands-of-toys-to-toys-for-tots-301223737.html

SOURCE SciPlay

Nugg Club Launches Schedule 1 Brand That Will Donate Portion of Profits to Support Descheduling Marijuana from Controlled Substances Act

LOS ANGELES, Feb. 8, 2021 /PRNewswire/ — Nugg Club, the nation’s first true cannabis subscription box featuring full-sized products curated by experts and personalized to each customer, announced today the launch of Schedule 1, a new cannabis brand that seeks to provide instrumental support towards the mission of declassifying marijuana as a controlled substance by the Drug Enforcement Agency (DEA). Specifically, proceeds from Schedule 1 will be donated to lobbying efforts that seek to reclassify…

LOS ANGELES, Feb. 8, 2021 /PRNewswire/ — Nugg Club, the nation’s first true cannabis subscription box featuring full-sized products curated by experts and personalized to each customer, announced today the launch of Schedule 1, a new cannabis brand that seeks to provide instrumental support towards the mission of declassifying marijuana as a controlled substance by the Drug Enforcement Agency (DEA). Specifically, proceeds from Schedule 1 will be donated to lobbying efforts that seek to reclassify marijuana, and to Last Prisoner Project to free individuals in prison on non-violent cannabis charges who are serving jail because of marijuana being defined as a Schedule I drug.

The Controlled Substances Act (CSA) places all substances which are in some manner regulated under existing federal law into one of five schedules. Drugs like marijuana, opioids and heroin are classified as Schedule I drugs and are defined as those with no currently accepted medical use and a high potential for abuse. They also carry heavy penalties and jail time, sometimes mandatory, in the criminal justice system.

Yet, according to the Marijuana Policy Project there are over 4.3 million patients in the U.S. who rely on cannabis to ease the symptoms caused by myriad conditions, from cancer to post traumatic stress disorder and epilepsy. In fact, the U.S. already has patents on cannabinoids, including THC, based on their ability to prevent age-related brain damage and trauma.

While some bills have supported rescheduling cannabis to a less harsh category, state-legal cannabis businesses would still be unprotected from federal prosecution. Rescheduling also wouldn’t protect private citizens from arrest. Nugg Club aims to have Schedule 1 create a self-sustaining platform that supports removing cannabis from the list of controlled substances and helps to free people incarcerated for nonviolent marijuana crimes due to federal scheduling.

«The federal Controlled Substances Act was written more than half a century ago and is based on flawed, unscientific and extremely outdated data. Cannabis is now commonly used to successfully treat intractable seizures, cachexia, chronic debilitating pain and many other life-threatening disorders. It’s proven its utility within the medical community, yet it’s still classified as Schedule I,» said Joe Brottman, Creative Director of Nugg Club. «We’re launching Schedule 1 to not only increase awareness but provide instrumental support to the mission to end the prison state.»

At launch, Schedule 1 will include three flower strains available in Nugg Club subscription boxes and online for members to purchase via the Nugg Club add-ons menu. The strains include:

  • Mimosa: This sativa-dominant strain is a cross between Purple Punch and Clementine. A daytime pick-me-up, Mimosa is great for chasing sleep away, relieving stress and sparking creativity. Its mood-boosting terpenes, limonene and beta caryophyllene, make for a zesty experience that tapers off gradually.
  • MAC 1: Directly sourced by legacy-grower Capulator, MAC 1 is a smooth hybrid strain with impressive plant parents — Alien Cookies crossed with Starfighter and a Columbian landrace (aka Miracle 15). Connoisseurs can trace spice, diesel, and sour citrus in the strain’s pungent aromas.
  • Sunset Cookies: A proprietary phenotype sourced from Thin Mint Cookies and Sherbet genetics, Sunset Cookies is carefully bred in Coachella Valley to produce a mellow hybrid boasting with notes of fruity blueberry and lavender citrus. Sunset Cookies provides a super sweet balance between hazy and clear-headed effects.

The launch of Schedule 1 follows the company’s recent announcement of a more broad-ranging partnership with Last Prisoner Project. This month, Nugg Club will be sending a special box to subscribers that is rebranded to showcase the names of people imprisoned across the country for nonviolent cannabis offenses. Products in the February box will feature brands that specifically support social justice work, including Schedule 1. The box will also include a call to action for Nugg Club members to participate in LPP’s «Letter to a Prisoner» program and donate to the organization.

«We’re at a unique turning point in history. It’s become clear that if we want to deschedule cannabis, it’s going to be up to us. We already have one-third of our population living in states that allow legal recreational marijuana. Yet we still have prisoners serving life sentences for weed–some for tiny amounts,» said Erik Murray, Last Prisoner Project Board Member. «Last Prisoner Project is proud to partner with Nugg Club at the launch of Schedule 1 so we can push for change in Congress and make sure our prisoners come home in the process.»

About Nugg Club

Nugg Club is California’s first subscription cannabis club and helps anyone explore the world of cannabis at 50-60% below retail. The company is redefining the cannabis shopping experience by surprising consumers each month with carefully curated premium products matched to their preferences, and helping brands to connect with thousands of eager customers. Nugg Club was launched in 2020 by the team behind NuggMD, the nation’s leading medical cannabis technology platform, serving patients in California, Nevada, New York, Oklahoma, Pennsylvania, Ohio, Missouri and now New Jersey. For more information about Nugg Club, visit nuggclub.com.

Media Contact
MATTIO Communications
nugg@mattio.com

Cision View original content:http://www.prnewswire.com/news-releases/nugg-club-launches-schedule-1-brand-that-will-donate-portion-of-profits-to-support-descheduling-marijuana-from-controlled-substances-act-301223488.html

SOURCE Nugg Club

GroGuru and Sentek form a Strategic Partnership in Support of Farmers’ Strategic Irrigation Management Needs

SAN DIEGO, Feb. 8, 2021 /PRNewswire-PRWeb/ — GroGuru, Inc., an innovator in precision agriculture and site-specific soil monitoring, and Sentek Technologies, a market and technology leader in soil moisture and salinity measurement, jointly announced today a strategic partnership which pairs Sentek’s Drill-&-Drop soil moisture probes and telemetry with the GroGuru® InSites Software as a Service (SaaS) for strategic irrigation management. GroGuru InSites uses machine learning and artificial…

SAN DIEGO, Feb. 8, 2021 /PRNewswire-PRWeb/ — GroGuru, Inc., an innovator in precision agriculture and site-specific soil monitoring, and Sentek Technologies, a market and technology leader in soil moisture and salinity measurement, jointly announced today a strategic partnership which pairs Sentek’s Drill-&-Drop soil moisture probes and telemetry with the GroGuru® InSites Software as a Service (SaaS) for strategic irrigation management. GroGuru InSites uses machine learning and artificial intelligence (AI) to bring farmers and agronomic consultants a simple yet powerful irrigation decision support platform.

GroGuru InSites helps farmers more efficiently manage irrigation while saving energy, and optimally using labor to make more money by maximizing crop yield. Key inputs used by GroGuru InSites include, but are not limited to, soil moisture, stage of crop growth, weather forecast, and predicted crop water use to bring together a full irrigation scheduling suite.

«GroGuru InSites delivers a simple, intuitive user interface to farmers and agronomic consultants that they can access on their computer, tablet or mobile device,» said Patrick Henry, President and CEO at GroGuru. «The partnership with Sentek expands the GroGuru market reach and ability to scale our SaaS offering more rapidly, allowing us to help more farmers more quickly. The power of Sentek hardware and telemetry coupled with the GroGuru InSites platform puts tremendous power at a farmer’s fingertips.»

«The partnership with GroGuru expands Sentek’s market reach, and provides the option of our soil moisture and salinity monitoring technologies combined with the GroGuru machine learning and AI engine in the Cloud,» said Rob Guy, Sales Director at Sentek Technologies. «The partnership with GroGuru expands the integrator solutions available to farmers, agronomic consultants, agriculture retailers, farming cooperatives, and precision agriculture dealers.»

GroGuru and Sentek continue to pursue opportunities for growth in the agriculture technology and precision irrigation sector.

About GroGuru

GroGuru, Inc. is a privately held company based in San Diego, CA, founded in 2014. GroGuru supplies precision soil and irrigation monitoring and management systems to the commercial agriculture industry. GroGuru is all about strategic irrigation management, helping farmers make more money by increasing crop yield and more efficiently using water in a sustainable way.

GroGuru has a patented wireless underground system (WUGS) for soil monitoring, an AI-based recommendation engine in the Cloud, and an intuitive farmer-friendly user interface that farmers can access on their tablet, computer or mobile device. GroGuru sells an innovative hardware-enabled subscription-based solution to farmers that enables optimal irrigation, as well as a software as a service (SaaS) product marketed as GroGuru® InSites.

GroGuru’s patented WUGS technology enables a permanent installation of soil sensors, even in annual field crops. GroGuru has been a part of the OCTANE LaunchPad, EvoNexus, AgLaunch, the Yield Lab, SVG-Thrive and Plug & Play AgTech accelerator programs.

About Sentek

Sentek Technologies was founded in 1991 to meet the demand from farmers for real insights into their irrigation decisions. With a team of specialists across agronomy, soil science, and irrigation technology their products are designed to provide accurate data to support better irrigation decisions.

Sentek designs, develops, manufactures, supports and globally distributes best-in-class technology for measuring and managing moisture, salinity and temperature of soil.

Sentek sensors, telemetry and software are also used in research and environmental projects and are sold and supported through a global network of highly trained distributors.

For Sentek editorial comments, please contact Rob Guy, Sales Director, Sentek Technologies, +61-8-8366-1900

Media Contact

Amanda Henry, Triple Peak Media, +1 (858) 761-2169, amanda@triplepeakmedia.com

Twitter, Facebook

 

SOURCE GroGuru